4DMedical Limited (ASX:4DX)
Australia flag Australia · Delayed Price · Currency is AUD
1.755
-0.175 (-9.07%)
Oct 17, 2025, 4:10 PM AEST

4DMedical Company Description

4DMedical Limited operates as a medical technology company in the United States and Australia.

The company engages in the medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging.

It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of potential emphysema software; LTA provides visualization and quantification of the lung textures; PHA Analysis, a cutting-edge, fully-automated imaging solution; XV LVAS, a lung airflow imaging software; and XV Scanner, a lung function scanner.

The company was incorporated in 2012 and is based in Carlton, Australia.

4DMedical Limited
4DMedical logo
CountryAustralia
Founded2012
IndustryMedical Devices
SectorHealthcare
Employees124
CEOAndreas Fouras

Contact Details

Address:
Melbourne Connect
Carlton, 3053
Australia
Phone61 3 9545 5940
Website4dmedical.com

Stock Details

Ticker Symbol4DX
ExchangeAustralian Securities Exchange
Fiscal YearJuly - June
Reporting CurrencyAUD
ISIN NumberAU0000095416
SIC Code7372

Key Executives

NamePosition
Dr. Andreas Fouras M.A.I.C.D., Ph.D.Founder, MD, Chief Executive Officer and Director
Matt TuckerChief Commercial Officer
Chris CoxInterim Chief Financial Officer and Financial Controller
Beth PlunkettSenior Legal Counsel
Dr. Aidan Jamison B.E., Ph.D.Senior Vice President of Engineering
Rachael TenkatenSenior Vice President of Product
Dr. Greg T. Mogel M.D.Chief Medical Officer
David Hannes B.S., M.B.A.Senior Vice President of Global Business Development